Insider Selling: Kewaunee Scientific (NASDAQ:KEQU) CEO Sells $80,500.68 in Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,854 shares of the firm’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $43.42, for a total transaction of $80,500.68. Following the sale, the chief executive officer directly owned 39,719 shares in the company, valued at approximately $1,724,598.98. The trade was a 4.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, October 1st, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.09, for a total transaction of $43,090.00.
• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $43.62, for a total transaction of $43,620.00.
• On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The shares were sold at an average price of $44.00, for a total transaction of $31,724.00.
• On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total transaction of $35,047.82.
• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total transaction of $29,992.00.

Kewaunee Scientific Price Performance

Shares of NASDAQ:KEQU opened at $42.86 on Friday. The firm’s 50 day moving average price is $51.64 and its 200-day moving average price is $45.24. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $71.33. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $123.01 million, a PE ratio of 10.38 and a beta of 0.68.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings data on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The firm had revenue of $71.10 million for the quarter.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on KEQU. Weiss Ratings reiterated a “hold (c+)” rating on shares of Kewaunee Scientific in a research note on Saturday, September 27th. Wall Street Zen upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Kewaunee Scientific presently has a consensus rating of “Hold”.

Institutional Investors Weigh In On Kewaunee Scientific

A number of institutional investors and hedge funds have recently added to or reduced their stakes in KEQU. Jane Street Group LLC bought a new stake in shares of Kewaunee Scientific during the fourth quarter valued at approximately $300,000. Goldman Sachs Group Inc. raised its position in shares of Kewaunee Scientific by 125.7% during the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock valued at $764,000 after buying an additional 10,803 shares during the last quarter. Punch & Associates Investment Management Inc. bought a new stake in shares of Kewaunee Scientific during the first quarter valued at approximately $788,000. OMERS ADMINISTRATION Corp bought a new stake in shares of Kewaunee Scientific during the first quarter valued at approximately $284,000. Finally, American Century Companies Inc. raised its position in shares of Kewaunee Scientific by 43.4% during the first quarter. American Century Companies Inc. now owns 49,182 shares of the technology company’s stock valued at $1,937,000 after buying an additional 14,889 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.